#CTICares: We value work-life balance & family time! Did you know? We proudly offer generous #ParentalLeave benefits to all our employees across the globe. Through our supportive work environment, our #CTIFamily can prioritize work-life balance, allowing us to leave a lasting impact in the #CRO industry to #MoveMedicineForward! Discover how CTI makes a global difference: www.ctifacts.com
CTI Clinical Trial and Consulting Services
Research Services
Covington, KY 55,791 followers
Moving Medicine Forward
About us
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com
- Website
-
http://www.ctifacts.com
External link for CTI Clinical Trial and Consulting Services
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Covington, KY
- Type
- Privately Held
- Founded
- 1999
Locations
Employees at CTI Clinical Trial and Consulting Services
Updates
-
Happy #IndependenceDay from our #CTIFamily! Today, we celebrate the courage of our founding fathers & honor the sacrifices made for our freedom. Thanks to their bravery, we continue #MovingMedicineForward & #AdvanceHealthcareSolutions.
-
-
#MovingMedicineForward: Congratulations to our friends at Asklepios BioPharmaceutical, Inc. (AskBio) on opening enrollment for REGENERATE-PD, a Phase 2 trial of AB-1005 in Parkinson’s disease. #AskBio, a #GeneTherapy company, has encouraging results from their Phase 1b study & 18-month data, promoting the survival of vulnerable brain cells affected by #Parkinson’s. We highlight AskBio for their commitment to advancing potential #ParkinsonsDisease research! Learn more about their research in the article linked below.
Today we announced the initiation of recruitment to REGENERATE-PD, a Phase 2 clinical study assessing the efficacy and safety of AB-1005, an investigational #genetherapy for the treatment of moderate-stage Parkinson’s disease. More than 10 million people worldwide suffer from Parkinson’s disease, with approximately 1 million living in the United States. #AskBio is dedicated to advancing research and embracing cutting-edge science to explore gene therapy solutions for this debilitating disease. For Medical Media – Read our press release here: https://lnkd.in/g478gFVH #ParkinsonsDisease
-
-
#ThinkGlobalActLocal: For Brain & #AlzheimersAwareness Month, we're raising global awareness & supporting the millions affected by #Alzheimer's disease & other #Dementias worldwide. #CTICares: We’re committed to #MovingMedicineForward, leading the way in #Neurology research. CTI’s Clinical Research Center (CRC) has conducted 16+ trials in this area, including Alzheimer's & Mild Cognitive Impairment. With our expertise in caring for complex & critically ill patients, let's shape the future of #NeurologyResearch together!
-
-
#ThinkGlobalActLocal: We're ready to put #Covington on the global #LifeSciences map! CTI is proud to join the OneNKY Alliance Center, a cutting-edge hub for Covington Life Sciences Partners & ten #NKY growth organizations. We celebrated a major milestone with the Topping Out ceremony, placing the final steel beam. #MovingMedicineForward: Opening Summer 2025, our state-of-the-art wet lab will occupy 15,000 sqft on the 2nd floor, housing several regional #biotech companies. We're excited to contribute to this achievement & move towards a unified #OneNKY!
-
-
#CTICares: Our #Diversity, #Equity, #Inclusion, & #Belonging (DEIB) Council embodies CTI's commitment to recognizing & embracing a multitude of perspectives, backgrounds, & experiences. At CTI, we're dedicated to #MovingMedicineForward & uniting our unique #CTIFamily through our global #DEIB committee. #ThinkGlobalActLocal: Learn how CTI thinks globally & acts locally at https://www.ctifacts.com/
-
-
Our #CTIFamily is dedicated to #MovingMedicineForward, with each team member playing a pivotal role in #AdvancingHealthcareSolutions through their unique perspectives & experiences!
The European and Australian CPC Teams came together in person and virtually to enjoy a full day together. As last week was the official start of summer in the western hemisphere and International T-shirt Day… the icebreaker basically wrote itself. We also know how to really lean into a theme 😉 While there was certainly some fun, the day was also filled with a lot of brainstorming around a better tailored onboarding program, discussions around eTMF processes and some wonderful guest speakers – thank you Helen Bethke, Jennifer Schroer & Gabriel Thompson for your time and insightful presentations! 💙 Thanks to the whole team for making this such a great day! 👕 #ctifacts #teamspirit #InternationalTshirtDay #SummerVibes #DYIdecorations #InternationalTeam #InternationalInclusion #InternationalCollaboration #TeamMeeting
-
-
#CTICares: Touching Lives for 25 Years! From humble beginnings to a global presence, our journey has been defined by commitment to touching lives & leaving a lasting imprint of excellence. CTI has been at the forefront of #MovingMedicineForward, contributing to the advancement of innovative transplant medicine, research, & development. With experience managing 130+ transplantation studies over the past 25 years, we aim to extend the longevity & enhance the quality of life for transplant recipients, marking a new era in transplant medicine! #CTI25Years #MovingMedicineSince1999 #TouchingLives #ImprintExcellence #MakeYourMark
-
-
#CTICares: Medical Director & #Oncology Expert, Richard Curry, MD emphasizes the importance of protecting your skin from the sun’s harmful rays. To safeguard your skin, apply SPF 30 sunscreen, wear protective clothing, & avoid peak sun hours. At CTI, we’re committed to #MovingMedicineForward, improving patients’ lives, & #AdvancingHealthcareSolutions!
-
#MovingMedicineForward: Congratulations to our friends at ProKidney Corp. on their positive interim REGEN-007 Phase 2 data. The trial evaluating ProKidney’s renal autologous cell therapy, rilparencel, in #ChronicKidneyDisease (CKD) patients has demonstrated stabilized #Kidney functions over 18 months, with no rilparencel-related adverse events reported in any study patients. We highlight ProKidney for their commitment to advancing potential #Dialysis prevention & #HealthcareSolutions for individuals with #CKD. Learn more about their research in the article linked below!